Department of Anesthesiology, University of Pittsburgh, Pittsburgh, PA 15261, U.S.A.
Biochem J. 2013 Jan 1;449(1):61-8. doi: 10.1042/BJ20121072.
pLGICs (pentameric ligand-gated ion channels) are a family of structurally homologous cation and anion channels involved in neurotransmission. Cation-selective members of the pLGIC family are typically inhibited by general anaesthetics, whereas anion-selective members are potentiated. GLIC is a prokaryotic cation pLGIC and can be inhibited by clinical concentrations of general anaesthetics. The introduction of three mutations, Y221A (Y-3'A), E222P (E-2'P) and N224R (N0'R), at the selectivity filter and one, A237T (A13'T), at the hydrophobic gate, converted GLIC into an anion channel. The mutated GLIC (GLIC4) became insensitive to the anaesthetics propofol and etomidate, as well as the channel blocker picrotoxin. MD (molecular dynamics) simulations revealed changes in the structure and dynamics of GLIC4 in comparison with GLIC, particularly in the tilting angles of the pore-lining helix [TM2 (transmembrane helix 2)] that consequently resulted in different pore radius and hydration profiles. Propofol binding to an intra-subunit site of GLIC shifted the tilting angles of TM2 towards closure at the hydrophobic gate region, consistent with propofol inhibition of GLIC. In contrast, the pore of GLIC4 was much more resilient to perturbation from propofol binding. The present study underscores the importance of pore dynamics and conformation to anaesthetic effects on channel functions.
pLGICs(五聚体配体门控离子通道)是一类结构同源的阳离子和阴离子通道,参与神经递质传递。pLGIC 家族中的阳离子选择性成员通常被全身麻醉剂抑制,而阴离子选择性成员则被增强。GLIC 是一种原核阳离子 pLGIC,可被临床浓度的全身麻醉剂抑制。在选择性过滤器处引入三个突变,Y221A(Y-3'A)、E222P(E-2'P)和 N224R(N0'R),以及在疏水性门处引入一个突变 A237T(A13'T),将 GLIC 转化为阴离子通道。突变的 GLIC(GLIC4)对麻醉剂异丙酚和依托咪酯以及通道阻滞剂 picrotoxin 变得不敏感。MD(分子动力学)模拟显示,与 GLIC 相比,GLIC4 的结构和动力学发生了变化,特别是在孔衬螺旋 [TM2(跨膜螺旋 2)] 的倾斜角度上,这导致了不同的孔径和水合轮廓。异丙酚结合到 GLIC 的一个亚基内位点会导致 TM2 的倾斜角度向疏水门区域的关闭方向移动,这与异丙酚抑制 GLIC 一致。相比之下,GLIC4 的孔对异丙酚结合的扰动更具弹性。本研究强调了孔动力学和构象对麻醉剂对通道功能影响的重要性。